96 related articles for article (PubMed ID: 19571675)
1. GSK3beta-cyclin D3-CUGBP1-eIF2 pathway in aging and in myotonic dystrophy.
Jin J; Wang GL; Salisbury E; Timchenko L; Timchenko NA
Cell Cycle; 2009 Aug; 8(15):2356-9. PubMed ID: 19571675
[TBL] [Abstract][Full Text] [Related]
2. Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver.
Timchenko LT; Salisbury E; Wang GL; Nguyen H; Albrecht JH; Hershey JW; Timchenko NA
J Biol Chem; 2006 Oct; 281(43):32806-19. PubMed ID: 16931514
[TBL] [Abstract][Full Text] [Related]
3. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26169-78. PubMed ID: 18622015
[TBL] [Abstract][Full Text] [Related]
4. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1.
Salisbury E; Sakai K; Schoser B; Huichalaf C; Schneider-Gold C; Nguyen H; Wang GL; Albrecht JH; Timchenko LT
Exp Cell Res; 2008 Jul; 314(11-12):2266-78. PubMed ID: 18570922
[TBL] [Abstract][Full Text] [Related]
5. The role of CUGBP1 in age-dependent changes of liver functions.
Jones K; Timchenko L; Timchenko NA
Ageing Res Rev; 2012 Sep; 11(4):442-9. PubMed ID: 22446383
[TBL] [Abstract][Full Text] [Related]
6. The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration.
Jin J; Wang GL; Shi X; Darlington GJ; Timchenko NA
Mol Cell Biol; 2009 Jul; 29(14):3867-80. PubMed ID: 19398579
[TBL] [Abstract][Full Text] [Related]
7. Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1.
Wei C; Stock L; Valanejad L; Zalewski ZA; Karns R; Puymirat J; Nelson D; Witte D; Woodgett J; Timchenko NA; Timchenko L
FASEB J; 2018 Apr; 32(4):2073-2085. PubMed ID: 29203592
[TBL] [Abstract][Full Text] [Related]
8. HDAC1 promotes liver proliferation in young mice via interactions with C/EBPbeta.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26179-87. PubMed ID: 18622014
[TBL] [Abstract][Full Text] [Related]
9. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional and translational regulation of C/EBPβ-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1α proteins at the early and late stages of liver cancer.
Jin J; Iakova P; Jiang Y; Lewis K; Sullivan E; Jawanmardi N; Donehower L; Timchenko L; Timchenko NA
J Biol Chem; 2013 May; 288(20):14451-14462. PubMed ID: 23564453
[TBL] [Abstract][Full Text] [Related]
11. RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2.
Timchenko NA; Wang GL; Timchenko LT
J Biol Chem; 2005 May; 280(21):20549-57. PubMed ID: 15788409
[TBL] [Abstract][Full Text] [Related]
12. GSK3β mediates muscle pathology in myotonic dystrophy.
Jones K; Wei C; Iakova P; Bugiardini E; Schneider-Gold C; Meola G; Woodgett J; Killian J; Timchenko NA; Timchenko LT
J Clin Invest; 2012 Dec; 122(12):4461-72. PubMed ID: 23160194
[TBL] [Abstract][Full Text] [Related]
13. GSK3beta and aging liver.
Jin J; Wang GL; Timchenko L; Timchenko NA
Aging (Albany NY); 2009 Jun; 1(6):582-5. PubMed ID: 20157540
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
[TBL] [Abstract][Full Text] [Related]
15. Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.
Timchenko L
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877772
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for impaired muscle differentiation in myotonic dystrophy.
Timchenko NA; Iakova P; Cai ZJ; Smith JR; Timchenko LT
Mol Cell Biol; 2001 Oct; 21(20):6927-38. PubMed ID: 11564876
[TBL] [Abstract][Full Text] [Related]
17. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients.
Salisbury E; Schoser B; Schneider-Gold C; Wang GL; Huichalaf C; Jin B; Sirito M; Sarkar P; Krahe R; Timchenko NA; Timchenko LT
Am J Pathol; 2009 Aug; 175(2):748-62. PubMed ID: 19590039
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy.
Lutz M; Levanti M; Karns R; Gourdon G; Lindquist D; Timchenko NA; Timchenko L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445828
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis.
Timchenko NA; Patel R; Iakova P; Cai ZJ; Quan L; Timchenko LT
J Biol Chem; 2004 Mar; 279(13):13129-39. PubMed ID: 14722059
[TBL] [Abstract][Full Text] [Related]
20. GSK3β is a new therapeutic target for myotonic dystrophy type 1.
Wei C; Jones K; Timchenko NA; Timchenko L
Rare Dis; 2013; 1():e26555. PubMed ID: 25003008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
